Caribou Biosciences, Inc. (CRBU)
NASDAQ: CRBU · Real-Time Price · USD
2.340
+0.070 (3.08%)
At close: Oct 6, 2025, 4:00 PM EDT
2.350
+0.010 (0.43%)
Pre-market: Oct 7, 2025, 6:36 AM EDT
Caribou Biosciences Market Cap
Caribou Biosciences has a market cap or net worth of $217.91 million as of October 7, 2025. Its market cap has increased by 16.50% in one year.
Market Cap
217.91M
Enterprise Value
59.81M
1-Year Change
16.50%
Ranking
Category
Stock Price
$2.34
Market Cap Chart
Since the IPO on July 23, 2021, Caribou Biosciences's market cap has decreased from $888.48M to $217.91M, a decrease of -75.47%. That is a compound annual growth rate of -28.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2025 | 217.91M | 51.35% |
| Dec 31, 2024 | 143.98M | -71.59% |
| Dec 29, 2023 | 506.71M | 32.27% |
| Dec 30, 2022 | 383.09M | -57.82% |
| Dec 31, 2021 | 908.30M | 2.23% |
| Jul 23, 2021 | 888.48M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 753.98B |
| Johnson & Johnson | 454.31B |
| AbbVie | 413.22B |
| UnitedHealth Group | 326.22B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 234.25B |